Plain-English translation of NCT07801495 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new medication called to see if it can help people with moderate to severe psoriatic arthritis (a condition where arthritis occurs alongside psoriasis skin disease). The trial will check whether the medication works better than a placebo and find the best dose to use.
People with psoriatic arthritis need better treatment options that are safe and effective. This medication represents a new approach, and researchers want to understand whether it can relieve joint symptoms and inflammation in patients with moderate to severe disease.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either or a placebo, and the study has two parts designed to test how well the medication works and find the right dose. Throughout the trial, you would attend visits at a research clinic where doctors would monitor your arthritis symptoms, check for side effects, and assess how you're responding to treatment. The study will help determine if this new medication can safely improve symptoms for people with psoriatic arthritis.
AI-generated summary from trial data · Oct 5, 2026 · Not medical advice
United States